Insider Transactions in Q4 2020 at Core Laboratories N V (CLB)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2020
|
Lawrence Bruno Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,384
-21.94%
|
$139,984
$26.51 P/Share
|
Dec 31
2020
|
Lawrence Bruno Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,682
+35.79%
|
-
|
Dec 31
2020
|
Christopher Scott Hill SVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,024
-5.78%
|
$26,624
$26.51 P/Share
|
Dec 31
2020
|
Christopher Scott Hill SVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+12.8%
|
-
|
Dec 31
2020
|
Kevin Daniels CAO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,024
-30.22%
|
$26,624
$26.51 P/Share
|
Dec 31
2020
|
Kevin Daniels CAO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+43.42%
|
-
|
Dec 31
2020
|
Mark F Elvig SVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
454
-3.52%
|
$11,804
$26.51 P/Share
|
Dec 31
2020
|
Mark F Elvig SVP, Gen Counsel & Secretary |
SELL
Other acquisition or disposition
|
Direct |
739
-5.42%
|
-
|
Dec 31
2020
|
Mark F Elvig SVP, Gen Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+16.01%
|
-
|
Dec 01
2020
|
Kevin Daniels CAO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
54
-6.41%
|
$1,242
$23.2 P/Share
|
Dec 01
2020
|
Kevin Daniels CAO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
140
+14.26%
|
-
|